U.S., June 11 -- An application to own the trademark for 'CYTAC' has been filed on May. 15, 2024.
Owner(s):
Solu Therapeutics, Inc.; 196 Boston Avenue, Suite 2500, , MASSACHUSETTS
Goods and/or Services:
For: pharmaceutical preparations for the treatment of cancers, immunological diseases, and inflammatory diseases; molecules for use in pharmaceutical preparations, namely, biological preparations for the treatment of cancers, immunological diseases, and inflammatory diseases
Class(es): 005, 006, 018, 044, 046, 051, 052
For: molecules for use in the development of pharmaceutical preparations, namely, biological preparations for scientific research use
Class(es): 001, 005, 006, 010, 026, 046
For: scientific research and development; re...